LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that it has released a major upgrade to its gold standard GastroPlus™ software for simulation of absorption, pharmacokinetics, and pharmacodynamics of drugs dosed in oral and intravenous dosage forms.
